Stockscreener 앱 받기
152.37
1.20%
1.81
전일 마감가:
$150.56
열려 있는:
$144.81
하루 거래량:
1.59M
Relative Volume:
1.72
시가총액:
$8.57B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-491.52
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
+6.69%
1개월 성능:
+2.68%
6개월 성능:
+19.00%
1년 성능:
+6.98%
1일 변동 폭
$144.81
$154.79
1주일 범위
$144.40
$158.74
52주 변동 폭
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
RGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
152.37 | 8.48B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-01 | 개시 | HSBC Securities | Buy |
| 2025-09-22 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-29 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 개시 | Evercore ISI | In-line |
| 2025-02-10 | 개시 | TD Cowen | Buy |
| 2024-12-17 | 개시 | Canaccord Genuity | Hold |
| 2024-11-14 | 개시 | Wolfe Research | Peer Perform |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 개시 | Guggenheim | Neutral |
| 2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 개시 | Wells Fargo | Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-03-28 | 개시 | The Benchmark Company | Buy |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-23 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 개시 | SVB Leerink | Outperform |
| 2019-08-28 | 재확인 | First Analysis Sec | Outperform |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
| 2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
| 2018-09-26 | 개시 | H.C. Wainwright | Neutral |
| 2017-12-08 | 개시 | Citigroup | Buy |
| 2017-12-05 | 개시 | JP Morgan | Overweight |
| 2017-11-13 | 개시 | CL King | Buy |
| 2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 개시 | William Blair | Outperform |
| 2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Is Repligen Corporation a good long term investmentPortfolio Allocation Tips & Market Volatility Strategies - earlytimes.in
Will Repligen Corporation (RGN) stock benefit from mergersLong Setup & Weekly Top Performers Watchlists - newser.com
There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - setenews.com
How to forecast Repligen Corporation trends using time seriesTrade Exit Summary & High Return Trade Opportunity Guides - newser.com
Using Python tools to backtest Repligen Corporation strategiesMarket Growth Report & Comprehensive Market Scan Reports - newser.com
Real time breakdown of Repligen Corporation stock performance - newser.com
How Repligen Corporation stock performs during Fed tightening cyclesJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com
Repligen stock rating reiterated at Buy by Stifel on strong business outlook - Investing.com
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know - Yahoo Finance
Repligen at Stifel Conference: Strong Growth Amid Challenges - Investing.com
Repligen at UBS Global Healthcare: Strategic Growth and Market Positioning - Investing.com
How Repligen Corporation stock trades before earningsEarnings Overview Report & Expert Approved Momentum Ideas - newser.com
Relative strength of Repligen Corporation in sector analysisPortfolio Return Report & Real-Time Market Sentiment Alerts - newser.com
Repligen Bets Big On Bioprocessing Innovation—But At A Price - Finimize
RGEN (Repligen) Scaled Net Operating Assets : 0.70 (As of Sep. 2025) - GuruFocus
Custom strategy builders for tracking Repligen CorporationMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Repligen (RGEN) to Release Earnings on Tuesday - Defense World
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN) - Yahoo Finance
Repligen Corporation (RGEN) Stock forecasts - Yahoo Finance UK
RGEN (Repligen) Other Gross PPE : $419.2 Mil (As of Sep. 2025) - GuruFocus
AlphaQuest LLC Makes New Investment in Repligen Corporation $RGEN - Defense World
Repligen Corporation (RGEN) Stock Forecasts - Yahoo! Finance Canada
RGEN (Repligen) YoY EBITDA Growth : 82.82% (As of Sep. 2025) - GuruFocus
Why retail investors pile into Repligen Corporation stockPortfolio Risk Report & Reliable Intraday Trade Alerts - Fundação Cultural do Pará
RGEN (Repligen) Cash And Cash Equivalents : $708.9 Mil (As of Jun. 2025) - GuruFocus
Repligen (RGEN): Assessing Valuation After Q3 Profits and Raised 2025 Guidance - Yahoo Finance
Does Repligen Corporation stock trade at a discount to peersJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Smart tools for monitoring Repligen Corporation’s price actionSwing Trade & Trade Opportunity Analysis - newser.com
RGEN (Repligen) EPS without NRI : $1.66 (TTM As of Jun. 2025) - GuruFocus
[10-Q] REPLIGEN CORP Quarterly Earnings Report | RGEN SEC FilingForm 10-Q - Stock Titan
Repligen (NASDAQ: RGEN) to join five investor conferences in November; webcast access - Stock Titan
Repligen Corporation to Present at Upcoming November Conferences - Yahoo Finance
Repligen (NASDAQ:RGEN) Cut to Hold at Wall Street Zen - MarketBeat
Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Should you hold or exit Repligen Corporation nowJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Versor Investments LP Sells 2,212 Shares of Repligen Corporation $RGEN - MarketBeat
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call - Yahoo Finance
Can volume confirm reversal in Repligen Corporation2025 Dividend Review & Short-Term High Return Ideas - newser.com
What technical patterns form on Repligen Corporation (RGN) stock chartsStock Surge & Stock Portfolio Risk Control - newser.com
Pier Capital LLC Sells 4,692 Shares of Repligen Corporation $RGEN - MarketBeat
Geneva Capital Management LLC Purchases 343,991 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corp (RGEN) Stock Price, Trades & News - GuruFocus
RGEN (Repligen) EBIT : $26.1 Mil (TTM As of Jun. 2025) - GuruFocus
Research Analysts Offer Predictions for Repligen Q1 Earnings - Defense World
William Blair Has Negative View of Repligen FY2025 Earnings - MarketBeat
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.23%
0.58%
자본화:
|
볼륨(24시간):